EV/EBITDA:
-16.760.00(0.00%)Summary
- As of today (June 28, 2025), TARS EV/EBITDA is -16.76, unchanged {tradingSession}.
- Over the past year, TARS EV/EBITDA has dropped by -11.27 (-205.28%).
- TARS EV/EBITDA is now -644.89% below its all-time high of -2.25.
Performance
TARS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TARS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | +0.1% | +0.1% |
| 1 m1 month | +3.9% | -3.9% | -3.6% |
| 3 m3 months | +14.1% | -23.6% | -20.3% |
| 6 m6 months | -12.4% | -15.9% | -26.6% |
| ytdytd | +14.8% | -24.2% | -27.1% |
| 1 y1 year | -205.3% | +102.1% | +60.3% |
| 5 y5 years | - | - | - |
TARS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -16.35 | -2.5% | -18.41 | +9.0% |
| 3 m | 3-month | -16.35 | -2.5% | -21.88 | +23.4% |
| 6 m | 6-month | -14.91 | -12.4% | -21.88 | +23.4% |
| 1 y | 1-year | -5.23 | -220.5% | -21.88 | +23.4% |
| 3 y | 3-year | -2.25 | -644.9% | -21.88 | +23.4% |
| 5 y | 5-year | -2.25 | -644.9% | -126.62 | +86.8% |
| alltime | all time | -2.25 | -644.9% | -126.62 | +86.8% |
TARS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.76(-14.8%) |
| 2024 | -19.66(+420.1%) |
| 2023 | -3.78(-34.8%) |
| Date | Value |
|---|---|
| 2022 | -5.80(-75.5%) |
| 2021 | -23.65(-5.4%) |
| 2020 | -25.00 |
FAQ
- What is Tarsus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
- What is TARS EV/EBITDA year-to-date change?
- What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
What is Tarsus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of TARS is -16.76
What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high EV/EBITDA is -2.25
What is TARS EV/EBITDA year-to-date change?
Tarsus Pharmaceuticals EV/EBITDA has changed by +2.90 (+14.75%) since the beginning of the year
What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, TARS EV/EBITDA has changed by -11.27 (-205.28%)